3天内，2家公司撤回IPO

Group 1 - The core viewpoint of the news is the acceptance of the IPO application of Ningbo Jianxin Superconducting Technology Co., Ltd. on the Sci-Tech Innovation Board, marking it as the third company to be accepted for IPO this year [1][2]. - Jianxin Superconducting focuses on the research, production, and sales of core components for medical magnetic resonance imaging (MRI) equipment, with its main products including superconducting magnets, permanent magnets, and gradient coils, which account for approximately 50% of the cost of MRI equipment [2][3]. - The company has established partnerships with well-known MRI equipment manufacturers such as Fujifilm, GE Healthcare, and others, positioning itself as a leading independent supplier of superconducting magnets globally [2][3]. Group 2 - Jianxin Superconducting's projected revenues for 2022 to 2024 are 359 million yuan, 451 million yuan, and 425 million yuan, respectively, with net profits of 34.63 million yuan, 48.73 million yuan, and 55.78 million yuan [3]. - The IPO aims to raise 865 million yuan for projects including the annual production of 600 sets of helium-free superconducting magnets and the technological transformation of high-field medical superconducting magnets [3]. - The acceptance of Jianxin Superconducting's IPO application highlights the ongoing effects of the "Eight Policies of the Sci-Tech Innovation Board," with a total of 13 IPOs accepted this year across various exchanges [3][8].